EP1068567A2 - Reseau neural artificiel de prediction de troubles respiratoires et sa methode de developpement - Google Patents

Reseau neural artificiel de prediction de troubles respiratoires et sa methode de developpement

Info

Publication number
EP1068567A2
EP1068567A2 EP99911125A EP99911125A EP1068567A2 EP 1068567 A2 EP1068567 A2 EP 1068567A2 EP 99911125 A EP99911125 A EP 99911125A EP 99911125 A EP99911125 A EP 99911125A EP 1068567 A2 EP1068567 A2 EP 1068567A2
Authority
EP
European Patent Office
Prior art keywords
netsum
rinp
information
predictive
sleep
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99911125A
Other languages
German (de)
English (en)
Inventor
Brydon J. B. Grant
Ali A. El-Solh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of State University of New York
Original Assignee
Research Foundation of State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of State University of New York filed Critical Research Foundation of State University of New York
Publication of EP1068567A2 publication Critical patent/EP1068567A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4806—Sleep evaluation
    • A61B5/4818—Sleep apnoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • A61B5/7267—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems involving training the classification device

Definitions

  • the present invention relates to an artificial neural network ("ANN”) for predicting respiratory disturbances, and a to method for developing such an (“ANN”) .
  • ANN artificial neural network
  • Regression models have been used to produce prediction rules for predicting whether an individual has a particular attribute, such as a sleeping disorder. Such regression models often use physical features and clinical traits indicative of a high probability of the attribute. However, the predictive rules produced by such regression models often lack specificity, and offer only a dichotomous output based on a predetermined cutoff value, particularly with respect to the apnea/hypopnea index ("AHI”) , which is an index related to obstructive sleep apnea (“OSA”) . Furthermore, to compound the deficiencies of such prediction rules, the predetermined cutoff value associated with a particular model is often selected arbitrarily, and furthermore, varies from model to model.
  • AHI apnea/hypopnea index
  • OSA obstructive sleep apnea
  • OSA has been recognized increasingly as an important public health problem with potentially serious cardiovascular and psychomotor morbidity, and possibly excessive mortality.
  • An increased awareness of the risks associated with OSA in recent years has led to an increase in the number of referrals to specialists and sleep laboratories.
  • Overnight polysomnography (“OPG”) is the standard reference test for diagnosing OSA.
  • OPG is an expensive, labor-intensive, and time consuming procedure.
  • the present invention provides an ANN for predicting respiratory disturbances, and a method for developing an ANN.
  • An object of the present invention is to provide a method of developing an ANN which results in a prediction having more specificity and having fewer dichotomous outputs than prior art prediction rules developed through regression analysis models.
  • Another object of the present invention is to take into account nonlinear relationships and intricate interrelationships among attributes of complex processes, such as a biological system. Another object of the present invention is to provide a screening test for predicting OSA which is less expensive to use, less labor-intensive to use, and less time consuming to use than OPG.
  • Figure 1 shows the steps of the ANN according to the present invention
  • Figure 2 shows the steps of the method for developing an ANN according to the present invention
  • Figure 3 shows demographics of a validation data set described herein
  • Figure 4 is a comparison between patients who participated in a sleep study described herein;
  • Figure 5 is a list of questions and statements used to develop the ANN of the present invention.
  • Figure 6 is a graph showing receiver operator characteristic curves used to develop and analyze the ANN of the present invention
  • Figure 7 is another graph showing receiver operator characteristic curves used to develop and analyze the ANN of the present invention.
  • Figure 8 shows the relation between the predicted and actual AHI for patients in the validation data set together with the point wise 95% confidence limits.
  • the present invention includes a method, referred to herein generally as an ANN, that can predict the AHI of patients suspected of OSA.
  • the ANN of the present invention uses a combination of anthropomorphic data and clinical information obtained from a patient to predict the AHI of that patient.
  • the AHI is indicative of the likelihood that an individual has OSA.
  • Fig. 1 shows the method steps of the present invention.
  • the present invention is also directed at a storage device, such as a floppy disk, having stored thereon computer readable code for causing a computer to execute all or a substantial portion of the ANN.
  • the present invention includes a method for developing an ANN, such as the ANN described herein.
  • Fig. 2 shows the method steps of this aspect of the present invention.
  • An ANN is a numerical processor that accepts multiple pieces of information, usually in digital form, performs calculations using the pieces of information, and produces results which state whether an attribute is likely to be present.
  • the pieces of information gathered as part of the method are answers given by a patient in response to certain questions and statements, and the result produced by the ANN is a predicted AHI.
  • the method begins (step 10) by gathering information in the form of answers and responses to questions and statements.
  • the information includes answers given by the patient to the following questions: (a) How old are you (in years)?, (b) How tall are you (in meters)?, (c) How much do you weigh (in kilograms)?, (d) What is your neck circumference (in centimeters)?, (e) Have you been told or been treated for high blood pressure? (if yes, enter "1", and if no, enter "0")-
  • the information gathered (step 10) from the patient also includes the responses given by the patient to a set of statements.
  • each possible response is associated with a number (step 12) .
  • the number is determined and used in subsequent steps of the method according to the present invention in lieu of the response itself.
  • the possible responses to each statement in the set of statements, and the number associated with each possible response are as follows: a response of
  • a response of "0” means strongly disagree or never
  • a response of "0.25" means disagree or rarely has occurred, but less than once per week
  • a response of "0.5” means somewhat agree or sometimes i.e. 1 to 2 times per week
  • a response of "0.75" means agree or frequently i.e. 3 to 4 times per week
  • a response of "1.0” means strongly agree or always or almost always i.e. 5 to 7 time per week.
  • the set of statements includes the following: (a) I am very sleepy during the daytime and struggle to stay awake, (b) At night, my sleep disturbs my bed partner's sleep, (c) I am told I snore in my sleep, (d) I am told I stop breathing in my sleep, (e) I suddenly wake up gasping for breath during the night, (f) I feel tired upon awakening and want to go back to sleep, (g) I have or have been told that I have restless legs, (h) My desire or interest in sex is less than it used to be.
  • Appendix A incorporated herein by reference, there is shown the source code for a computer program called "sleep.prg" which will cause a computer to prompt the user of such a computer for responses to the questions and statements discussed above.
  • a computer having sleep.prg running thereon expedites the step of gathering (step 10) the answers and responses from the patient.
  • Sleep.prg is shown in Appendix A written in Clipper, but other computer languages can be used to gather the answers to the questions and responses to the statements discussed above.
  • sleep. prg accepts measurements in the English or metric system, and may convert entries to a different measurement system. In addition, sleep.
  • prg accepts responses to each statement in the set of statements in the form of a number 1 through 5, but then converts each response entered by the user into a number 0 through 1, as discussed above. Finally, sleep. prg puts the answers and responses in a string so that such information can be quickly accepted and processed by means for executing subsequent steps of the method, discussed below.
  • Appendix B is the source code for a computer program called "sleepnet . for" which executes subsequent steps of the ANN according to the present invention.
  • Sleepnet. for is shown in Appendix B written in Fortran, but other computer languages can be used to cause a computer to execute the steps according to the ANN.
  • sleepnet. for is written to accept the answers and responses discussed above in the format produced by sleep. prg.
  • X(l) through X(13) will be used herein to indicate the numerical values associated with the answers and responses (described above) given by a patient.
  • X(l) relates to the patient's age
  • X(2) relates to the patient's height
  • X(3) relates to the patient's neck circumference
  • X(4) relates to the patient's blood pressure
  • X(5) relates to whether the patient is sleepy during the daytime.
  • X( ⁇ ) relates to whether the patient disturbs the bed partner
  • X(7) relates to whether the patient snores
  • X(8) relates to whether the patient stops breathing while sleeping
  • X(9) relates to whether the patient suddenly wakes up gasping for breath.
  • X(10) relates to whether the patient is tired upon awakening
  • X(ll) relates to whether the patient has restless legs
  • X(12) relates to the patient's desire to have sex
  • X(13) relates to the patient's weight.
  • a BMI value is determined.
  • the BMI value is determined by dividing X(13) by the square of X(2).
  • twelve revised input values herein referred to as RINP(l) through RINP(12), are determined as indicated in Appendix B from the numerical values X(l) through X(13).
  • RINP(l) relates to age
  • RINP(2) relates to the BMI calculated
  • RINP(3) relates to neck circumference
  • RINP(4) relates to blood pressure
  • RINP(5) relates to being sleepy during the daytime.
  • RINP( ⁇ ) relates to disturbing the bed partner
  • RINP(7) relates to snoring
  • RINP(8) relates to stopping breathing while sleeping
  • RINP(9) relates to suddenly waking up gasping for breath.
  • RINP(IO) relates to being tired upon awakening
  • RINP(ll) relates to restless legs
  • RINP(12) relates to desire to have sex.
  • a first set of predictive indicators the components of which are referred to herein as "feat2” is determined.
  • Feat2 includes twenty-one (21) predictive indicators shown in Appendix B as feat2(l) through feat2(21), and are determined as shown in Appendix B from the revised input values RINP(l) through RINP(12).
  • a second set of predictive indicators the components of which are referred to herein as "feat3” is determined.
  • Feat3 includes twenty-one (21) predictive indicators shown in Appendix B as feat3(l) through feat3(21), and are determined as shown in Appendix B from the revised input values RINP(l) through RINP(12).
  • RINP(l) through RINP(12) are combined with the first and second sets of predictive indicators as shown in Appendix B to produce a first predictive number, labeled "output" in Appendix B.
  • the first predictive number is a number between 10 and -10.
  • the calculations shown in Appendix B may be adjusted to provide for AHI thresholds different from 10 per hour, and the present invention is not limited to the first predictive number ("output") being between 10 and -10.
  • a second predictive number, labeled "al” in Appendix B is determined as shown in Appendix B.
  • the second predictive number, al, once manipulated according to Appendix B, is the predicted AHI and in the final step 26, is provided to a health professional, such as a physician.
  • the present invention also includes a method for developing an ANN, such as the ANN described above.
  • the method for developing an ANN is described by way of the example which follows and in Fig. 2.
  • the ANN described above is further described and explained by the example which follows.
  • a first step 50 of the method for developing an ANN relevant information which is needed to make the desired prediction is determined.
  • a next step 52 of the method for developing an ANN clinical studies are performed to determine which patients have a particular attribute.
  • patients were referred to the Sleep Center at Buffalo General Hospital between November 1995 and August 1996 and were identified retrospectively from the sleep registration records and represented the derivation cohort. The majority of patients were referred by internists (54%), internal medicine subspecialists (36%), or ear, nose and throat surgeons (7%) .
  • sleep studies OPG were performed on two hundred ninety three patients during this period. Patients were excluded if they had been previously treated for sleep apnea, referred for a specific sleep disorder other than sleep apnea, or they failed to complete the sleep study.
  • patients give answers to questions and respond to statements and these answers and statements are gathered for further analysis.
  • a questionnaire related to sleep symptoms and motor functions was filled out by all patients prior to undergoing OPG. Demographic information (age, gender) and anthropomorphic measurements (neck circumference, height, and weight) were obtained on each patient.
  • the questionnaire administered to each patient sought answers and responses about a range of clinical variables thought to contribute or raise suspicion of sleep apnea. Nineteen (19) questions were subjected to detailed analysis.
  • the questions had a six-item Likert response with the following options: never (or strongly disagree) , rarely (or disagree) , sometimes (or somewhat agree), frequently (somewhat agree), always (strongly agree) , and not sure (or not applicable) .
  • the presence of hypertension and the amount of alcohol ingestion were determined by patient's self report.
  • OPG OPG was conducted on all patients enrolled in the study at the Sleep Center. Continuous electroencephalogram, electroculogram, electrocardiogram, and submental electromyogram were recorded. Airflow was assessed with an oral and nasal thermistor (Graphic Control; Buffalo, NY) , and arterial oxyhemoglobin saturation was measured with a pulse oximeter with the probe placed on the patient's finger (Biox IIA or 3700, Ohmeda; Louisville, CO) . Abdominal wall and rib cage motions were recorded with an inductive plethysmograph (Respitrace Corporation; Ardsley, NY) . AH data were recorded on a 16-channel polygraph and digitized on a computerized system (Aekitron Medical; Minneapolis, MN) .
  • apnea was defined as a reduction in airflow of >80% at the nose and the mouth for at least 10 sec.
  • Hypopnea was defined as a 50% reduction in oronasal airflow associated with either a 4% or greater decrease in oxygen saturation, or an arousal.
  • Arousal was defined according to the recent ASDA position paper (ASDA Report, EEG arousals: scoring rules and examples, Sleep 1992; 15:173-5).
  • the record was scored manually by a polysomnography technician and reviewed by a physician certified in sleep medicine.
  • the number of apneas and hypopneas per hour of total sleep time was derived, and reported as the apnea-hypopnea index (AHI) .
  • a positive sleep study for sleep apnea was defined as a AHI>10/hour, other thresholds were also considered (>15 or >20/hour) to determine the effect of altering the definition on the diagnostic accuracy of the predictive models.
  • the answers and responses are statistically analyzed to determine relationships between the answers and responses and the results of the clinical studies for the patients.
  • descriptive statistics for continuous variables were expressed as mean ⁇ 1 SD (standard deviation) . Difference in mean values was assessed using Student's t test. All tests were two tailed and statistical significance was set at a p value of less than 0.05.
  • Commercially available software were used for the multiple linear regression and regression tree (S-Plus, Statsci, Seattle, WA) , artificial neural networks (Neuroshell 2, Ward Systems, Frederick, MD) , and for confidence interval analyses (CIA, British Medical Journal, London, UK) .
  • a logarithmic transformation of AHI was used for both the ANN and the multiple linear regression in order to achieve a normal distribution of residuals.
  • the variables used as inputs for the ANN were selected from the list of items obtained from the patient' s questionnaire and from anthropomorphic measurements.
  • the classification and regression tree was used to choose those variables more likely to influence the predictive properties of the ANN. Because logistic regression models sometimes perform better than a decision tree, a logistic regression was also performed to identify predictor variables.
  • the independent variables were scaled to a value over a range between -1 and 1.
  • the responses to the Likert scale values were spaced equally at intervals of 0.5 over this range. Missing values and responses marked as "not applicable" were substituted with the class mean.
  • the relationships determined in the prior step are expressed mathematically.
  • the ANN described in this study was based on three layers: an input layer with 12 nodes, an output layer with a linear function and a hidden layer.
  • the hidden layer consisted of a direct connection between the input and the output layers, and two groups of 21 nodes with differing activation functions.
  • the activation function describes the nature of the linkage between the input layer and the hidden layer.
  • a Gaussian function was used for one group and a hyperboric function (tanh) for the other. Connections and outputs from the two groups in the hidden layer were linked to the output layer by linear functions.
  • Each link was assigned a coefficient or weights that was updated during the learning process. The weights are assigned initially at random between -0.6 and +0.6.
  • the mathematically expressed relationships are exposed to a training set during which the mathematical relationships are presented with a set of input and output patterns.
  • the inputs are fed into the mathematical relationships and the corresponding outcome is computed. The difference between the actual and desired outcome is propagated backward. Adjustments to connection weights in the mathematical relationships are made to minimize the error between the output predicted by the mathematical relationships and the measured attribute, in this example, the AHI.
  • the mathematical relationships are tested at regular intervals to determine the prediction error on a subset of data (evaluation data set) that is not included in the training process. As training proceeds, the prediction error on the evaluation data set decreases initially but then increases when overtraining occurs.
  • the mathematical relationships that produce the smallest error are selected (step 62) for further analysis.
  • a tenfold cross validation approach was used for evaluation.
  • the entire data set of 189 patients was divided with a random number generator into ten subsets.
  • Nine out of the ten subsets was pooled and used for training.
  • the data from the tenth subset was used as an evaluation set during training.
  • the entire process was repeated nine additional times by rotating the subset that was used as the evaluation set during training.
  • the mean square error was computed for each of ten sets of mathematical relationships on the entire derivation data set.
  • the mean square errors were averaged and the set of mathematical relationships that had a mean square error closest to the average was selected.
  • a multiple linear regression was employed to develop a model of AHI score based on the same independent variables used in the chosen set of mathematical relationships. Interaction terms were not included to determine the extent to which non-linearities and interaction terms contributed to the predictive accuracy of the chosen set of mathematical relationships .
  • the predictive model embodied by the chosen set of mathematical relationships is tested on an entirely different set of patients (validation cohort) that were not included in the derivation set.
  • the validation cohort used to develop the above described ANN comprised all patients who underwent a sleep study between September 1996 and December 1996. Patients were excluded from the study if they had been previously treated for sleep apnea, referred for a specific sleep disorder other than sleep apnea, or they failed to complete the sleep study. Then, a receiver operator characteristic (ROC) curve was generated for the chosen set of mathematical relationships.
  • ROC receiver operator characteristic
  • the ROC curve represents a graphic display of the true positives (sensitivity) plotted against the false positives (1-specificity) for various thresholds that are used to define sleep apnea.
  • the c-index was used to estimate diagnostic accuracy.
  • the c-index is equivalent to the area under the ROC curve. In brief, it is calculated by determining the probability of diagnosing sleep apnea correctly in every possible pair of patients: one who has sleep apnea, the other who does not.
  • a bootstrap method was used to calculate directly this measure of accuracy by generating 1000 data sets from a database by random sampling with replacement. Comparisons between the c-index for both models were assessed based on the confidence intervals. Statistical significance was accepted at the 5% level.
  • the derivation cohort was comprised of 189 patients, 66% males and 34% females. There were no significant differences in age, gender ratio, body mass index or neck circumference of patients of the derivation data set compared with the validation data set as, shown in Fig.3.
  • the average of the mean square error of the ten ANNs performed was 0.089 (range 0.174-0.023).
  • the ANN selected and described above had a mean square error of 0.092.
  • the correlation coefficient from the ANN's predicted values of AHI and the actual values in the derivation set was 0.856.
  • the corresponding correlation coefficient for the multiple linear regression with the same predictor variables was 0.509. This value was significantly less than the correlation coefficient obtained with the ANN (p ⁇ 0.01) .
  • Fig. 6 The performance of the ANN using a dichotomous definition of OSA is shown in Fig. 6 for the derivation data set as ROC curves.
  • Fig. 7 the performance of the ANN using a dichotomous definition of OSA is shown in Fig. 7 for the validation data set as ROC curves.
  • the c-index was 0.96 ⁇ 0.0191 SE, 0.951 ⁇ 0.0203 SE, and 0.935 ⁇ 0.0274 SE when OSA is defined as an AHI of >10, >15 and >20/hour respectively. There were no statistically significant differences between these c-indices or with the corresponding c-indices obtained with the derivation data set.
  • Fig. 8 shows the relation between the predicted and actual values of AHI for the patients in the validation data set together with the point wise 95% confidence limits. Only one of the 80 values (1.25% 95%CI : 0-6.7%) fell outside of the 95% confidence limits.
  • the present invention is a method, in the form of an ANN, which takes into account nonlinear relationships and intricate interrelationships among attributes of a complex process.
  • the present inventions also presents a method for developing an ANN which results in a prediction having more specificity and fewer dichotomous outputs than prior art prediction rules developed through regression analysis modes. It is therefore apparent that the present invention accomplishes the intended objects described above.
  • embodiments of the present invention have been described in detail herein, the present invention is not limited to such embodiments and is limited by the appended claims. -13- Appendix A
  • x(13) is WT lbs - declare x[13] or r ⁇ - 1 to 13 x.m] - 0.0 next hti - 0 htc - 0 wtp - 0 wtlc - 0 nci - 0 ncc « ⁇ 0 done - 1 do while donefO

Abstract

Méthode de prédiction de troubles respiratoires et méthode de développement d'un réseau neural artificiel. Les entrées dans la méthode et le réseau neural artificiel de la présente invention sont les réponses données par une personne à une série de questions. Le résultat en sortie du réseau neural artificiel est un indice théorique de troubles respiratoires.
EP99911125A 1998-03-06 1999-03-05 Reseau neural artificiel de prediction de troubles respiratoires et sa methode de developpement Withdrawn EP1068567A2 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7714898P 1998-03-06 1998-03-06
US7713298P 1998-03-06 1998-03-06
US77148P 1998-03-06
US77132P 1998-03-06
PCT/US1999/004808 WO1999045452A2 (fr) 1998-03-06 1999-03-05 Reseau neural artificiel de prediction de troubles respiratoires et sa methode de developpement

Publications (1)

Publication Number Publication Date
EP1068567A2 true EP1068567A2 (fr) 2001-01-17

Family

ID=26758924

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99911125A Withdrawn EP1068567A2 (fr) 1998-03-06 1999-03-05 Reseau neural artificiel de prediction de troubles respiratoires et sa methode de developpement

Country Status (5)

Country Link
EP (1) EP1068567A2 (fr)
JP (1) JP2002505892A (fr)
AU (1) AU2984499A (fr)
CA (1) CA2323059A1 (fr)
WO (1) WO1999045452A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1418968A4 (fr) * 2001-07-19 2009-11-18 Resmed Ltd Assistance respiratoire sous pression de patients
BRPI0914093A2 (pt) * 2008-10-15 2015-10-27 Koninkl Philips Electronics Nv sistema configurado para a detecção de insuficiência respiratória, método de detecção de insuficiência respiratória
KR102327062B1 (ko) * 2018-03-20 2021-11-17 딜로이트컨설팅유한회사 임상시험 결과 예측 장치 및 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5839438A (en) * 1996-09-10 1998-11-24 Neuralmed, Inc. Computer-based neural network system and method for medical diagnosis and interpretation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9945452A2 *

Also Published As

Publication number Publication date
JP2002505892A (ja) 2002-02-26
AU2984499A (en) 1999-09-20
WO1999045452A2 (fr) 1999-09-10
CA2323059A1 (fr) 1999-09-10
WO1999045452A3 (fr) 1999-11-18

Similar Documents

Publication Publication Date Title
US6083173A (en) Artificial neural network for predicting respiratory disturbances and method for developing the same
US20050131283A1 (en) Method for predicting apnea-hypopnea index from overnight pulse oximetry readings
Magalang et al. Prediction of the apnea-hypopnea index from overnight pulse oximetry
Whittle et al. Use of home sleep studies for diagnosis of the sleep apnoea/hypopnoea syndrome.
Mador et al. Prevalence of positional sleep apnea in patients undergoing polysomnography
Golpe et al. Home sleep studies in the assessment of sleep apnea/hypopnea syndrome
Hilton et al. Evaluation of frequency and time-frequency spectral analysis of heart rate variability as a diagnostic marker of the sleep apnoea syndrome
Baldwin et al. Associations between gender and measures of daytime somnolence in the Sleep Heart Health Study
Dalston et al. The identification of nasal obstruction through clinical judgments of hyponasality and nasometric assessment of speech acoustics
US20020002327A1 (en) Method for detecting cheyne-stokes respiration in patients with congestive heart failure
Mayer et al. Simultaneous laboratory-based comparison of ResMed Autoset with polysomnography in the diagnosis of sleep apnoea/hypopnoea syndrome
Fomas et al. Measurement of general health status in obstructive sleep apnea hypopnea patients
Breugelmans et al. Differences in patient and bed partner–assessed quality of life in sleep-disordered breathing
El-Solh et al. Validity of neural network in sleep apnea
Cabrero-Canosa et al. An intelligent system for the detection and interpretation of sleep apneas
Abaza et al. Classification of voluntary cough sound and airflow patterns for detecting abnormal pulmonary function
Zheng et al. Comparison of six assessment tools to screen for obstructive sleep apnea in patients with hypertension
Pillar et al. Predictive value of specific risk factors, symptoms and signs, in diagnosing obstructive sleep apnoea and its severity
Parekh et al. Endotyping sleep apnea one breath at a time: an automated approach for separating obstructive from central sleep-disordered breathing
Arslan et al. Validation of the NoSAS score for screening sleep-disordered breathing: A sleep clinicbasedstudy in Turkey
Steltner et al. Diagnosis of sleep apnea by automatic analysis of nasal pressure and forced oscillation impedance
Bardwell et al. Response bias influences mental health symptom reporting in patients with obstructive sleep apnea
Otero et al. Evaluation of an alternative definition for the apnea-hypopnea index
WO1999045452A2 (fr) Reseau neural artificiel de prediction de troubles respiratoires et sa methode de developpement
Pataka et al. During economic crisis can sleep questionnaires improve the value of oximetry for assessing sleep apnea?

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001006

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT DE ES FR GB IT NL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20021001